Emerging Infectious Disease ISSN: 1080-6059

SARS Antibody Test for Serosurveillance

Po-Ren Hsueh*¹, Chuan-Liang Kao*¹, Cun-Nan Lee*, Li-Kuan Chen†, Mei-Shian Ho‡, Charles Sia§¶, Xin De Fang§, Shugene Lynn¶, Tseng Yuan Chang§, Shi Kau Liu§, Alan M. Walfield§, and Chang Yi Wang§¶

Author affiliations: *National Taiwan University College of Medicine, Taipei, Taiwan; †Tsu Chi University, Hualien, Taiwan; ‡Academia Sinica, Taipei, Taiwan; §United Biomedical, Inc., Hauppauge, New York, USA; ¶United Biomedical, Inc. Asia, Hsin Chu, Taiwan; 1Drs. Hsueh and Kao contributed equally to this article.

Main Article

Figure 2

Time of seroconversion from onset of fever for patients infected with severe acute respiratory syndrome–associated coronoavirus. Cutoff absorbance shown by dotted line.

Figure 2. Time of seroconversion from onset of fever for patients infected with severe acute respiratory syndrome–associated coronoavirus. Cutoff absorbance shown by dotted line.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.